http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-000242-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69dd830162aa7d47bb6d4faf9117a797
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J29-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B39-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B39-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B39-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J29-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J29-89
filingDate 1997-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e26fe407c4b51161c2e1903ff7738f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6812deb1f66bdc80bd27bfdfdd3febb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a895a3e847c215cfb91430c745a77594
publicationDate 1999-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-000242-B1
titleOfInvention ZEOLITE ERS-10 AND METHOD FOR ITS PREPARATION
abstract 1. A porous crystalline material designated ERS-10 zeolite having in its calcined and anhydrous form a molar composition of oxides corresponding to the general formula (I) mM2/nOxzX2O3xYO2 (I), wherein: m is a number of between 0.01 and 10, M is H<+> and/or a cation of an alkaline or earth-alkaline metal with valence n, z is a number between 0 and 0.02, X represents one or more elements selected from aluminum, iron, gallium, boron, vanadium, arsenic, antimony, chromium and manganese and Y represents one or more elements selected from silicon, germanium, titanium, zirconium, characterized by an X-ray diffraction spectrum of the powders shown in table 1. 2. The porous crystalline material according to Claim 1, wherein M is selected from sodium, potassium, hydrogen or their mixtures. 3. The porous crystalline material according to Claim 1, wherein X is aluminum or aluminum partially substituted with an element selected from iron, gallium, boron, vanadium, arsenic, antimony, chromium and manganese. 4. The porous crystalline material according to Claim 1, wherein Y is silicon or silicon partially substituted with an element selected from germanium, titanium and zirconium. 5. A process for the preparation of the porous crystalline material ERS-10 according to Claim 1, which comprises: (a) preparing an aqueous solution optionally containing at least one compound capable of hydrolyzing to X2O3, at least one compound capable of hydrolyzing to YO2 a cation source of an alkaline or earth-alkaline metal and an organic templating agent (Q) characterized in that said templating agent is an azo spiro compound having general formula (II) wherein: n and n', the same or different, represent an integer between 3 and 6 and X<-> is an anion selected from OH<->, chloride, bromide, fluoride and iodide-ion, and wherein the quantity of reagents is such as to respect the following molar ratios: YO2/X2O3 from 50/1 to infinity OH<->/YO2, from 0.15/1 to 0.7/1 Q/YO2, from 0.1/1 to 0.5/1 H2O/YO2, from 20/1 to 60/1 M<+/>Y2 from 0.05/1 to 0.20/1 (b) maintaining the solution obtained in (a) under sufficient conditions to form a solid crystalline material; (c) drying the solid crystalline material which in its anhydrous form has a molar composition of oxides, corresponding to the general formula (III) YQ2OxmM2/nOxZX2O3xYO2 (III), wherein: y has a value of between 0.1 and 1, Q is the organic templating agent having general formula (II), M is a cation of an alkaline and/or alkaline earth metal and m, n, z, X and Y have the same meaning defined above; (d) calcining the crystalline material (III) obtained in step (c); and finally (e) at least partly substituting the cation M with H to obtain the ERS-10 zeolite having general formula (I) in acid form. 6. The process according to Claim 5, characterized in that in step a) the compound capable of hydrolyzing to X2O3 is selected from aluminum isopropylate, aluminum sulfate, NaAlO2. 7. The process according to Claim 6, wherein the aluminum compound is selected from aluminum isopropylate and aluminum sulfate. 8. The process according to Claim 5, characterized in that in step a) the compound capable of hydrolyzing to YO2 is a silicon compound selected from tetraethylorthosilicate, colloidal silica, sodium silicate, pyrophoric silica. 9. The process according to Claim 8, characterized in that the silicon compound is selected from tetraethylorthosilicate, colloidal silica. 10. The process according to Claim 5, characterized in that the sources of cations are sodium or potassium hydroxide. 11. The process according to Claim 5, characterized in that the organic templating agent (Q) is a compound having formula (II) wherein n and n', the same as each other, have a value equal to 5 and X<-> is OH<-> 12. The process according to Claim 5, characterized in that the quantity of constituents of the solution is such as to respect the following molar ratios: SiO2 /X2O3 from 80/1 to infinity OH<->SiO2, from 0.2/1 to 0.45/1 Q/SiO2 from 0.2/1 to 0.3/1 H2O/SiO2 from 40/1 to 50/1 M<+> SiO2 from 0.09/1 to 0.15/1. 13. The process according to Claim 5, characterized in that in step b) the reaction is carried out at a temperature of between 150 degree C and 180 degree C and for a time of from 3 to 28 days. 14. The process according to Claim 13, characterized in that the temperature is about 170 degree C and the reaction time is between 7 and 14 days. 15. The process according to Claim 5, characterized in that in step c) the drying is carried out at temperatures up to 170 degree C. 16. The process according to Claim 15, characterized in that said drying is carried out at temperatures of between 90 to 120 degree C. 17. The process according to Claim 5, characterized in that in step (d) the calcination is carried out at a temperature of between 500 and 700 degree C and for a time of between 4 and 20 hours. 18. The process according to Claim 17, characterized in that the calcination is carried out at a temperature of between 550 and 650 degree C and for a time of from 6 to 15 hours. 19. The process according to Claim 5, characterized in that in step (e), the substitution is carried out by ion exchange using a mineral acid such as hydrochloric acid or an ammonium salt such as ammonium acetate. 20. Zeolitic precursor having in its anhydrous form a molar composition of oxides corresponding to general formula (III) YQ2 OxmM2/h O.zX2O3xYO2 (III) wherein: Y has a value of between 0.1 and 1, Q is the organic templating agent having general formula (II) wherein: n and n', the same or different, represent an integer between 3 and 6 and X<-> is an anion selected from OH<->, chloride, bromide, fluorlde and iodide, M is a cation of an alkaline or alkaline earth metal with valence n, z is a number between 0 and 0.02, X represents one or more elements selected from aluminum, iron, gallium, boron, vanadium, arsenic, antimony chromium and manganese and Y represents one or more elements selected from silicon, germanium, titanium, zirconium, characterized by an X-ray diffraction spectrum of the powders shown in table 2. 21. Use of the porous crystalline material ERS-10 according to Claims 1 to 19 as molecular sieve, ion exchanger and in a catalytic process for the conversion of hydrocarbons.
priorityDate 1996-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1614757-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5268161-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5106801-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9629284-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1745678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5271921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5425933-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4508837-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1610777-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1188096-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5252527-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449845984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157745990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453924777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450647129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458391465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450664886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448467028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24884257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448367678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451289241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5461123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453148806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6517

Total number of triples: 104.